Hong Kong SAR
-
SAR’s rare debt issuance is increasing under green banner
-
Yachtmaker’s Chinese shareholder floated Ferretti in Hong Kong to get a better valuation
-
HK-based banker has been part of the bank’s DCM origination team for 13 years
-
Sovereign prices landmark tokenised green bond using blockchain technology, setting template for others
-
-
-
Market did not take well to the deal, which triggered a 15% fall in the firm's share price
-
Chinese stent maker dashes out for a listing before Christmas
-
Mala snacks maker has parked over half of its deal with cornerstones
-
Chinese developer has missed a coupon payment on an exchangeable bond amid tight liquidity
-
Deal comes as lenders remain cautious about risks in the real estate industry
-
The two firms are testing investor appetite for their listings
-
The developer is looking to extend the maturity of its dollar bond by two years
-
Chinese cancer immunotherapy drug producer parks over half of the deal with cornerstone investors
-
Gaush Meditech is seeking about $80m, and Weilong Global roughly $200m
-
Investors supported the deal, which allowed the group to replenish its funding at a lower cost
-
Chinese developers are facing legal action as outlook for the sector remains negative
-
-
-
Chinese insurance provider will start taking investor orders at the end of November
-
Chinese nickel producer's deal size takes a hit due to 'gloomy' market outlook
-
CoGard, Agile raise funding through ‘win-win’ deals but bankers warn market optimism may not last long
-
Another developer rushes to the equity capital market for funds
-
State-backed bank benefitted from a turn in sentiment towards Chinese credits